PHILADELPHIA, PA / ACCESSWIRE / April 18, 2020 / Kaskela Law LLC is investigating Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (NASDAQ:MMSI) on behalf of the Company's ...
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
Merit Medical (MMSI) delivered earnings and revenue surprises of 40.74% and 5.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Investor confidence is high in Merit Medical (MMSI) stock, thanks to solid prospects.
Pomerantz LLP is investigating claims on behalf of investors of Merit Medical Systems, Inc. (“Merit Medical” or the “Company”) (NASDAQ: MMSI). The investigation concerns whether Merit Medical and certain of its officers and/or directors have breached fiduciary duties owed to the company and its investors. If you are a shareholder of Merit Medical and are interested in obtaining additional information regarding this investigation, you are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext.
Q1 2020 Merit Medical Systems Inc Earnings Call
NEW YORK, NY / ACCESSWIRE / April 23, 2020 / Merit Medical Systems, Inc. (NASDAQ:MMSI) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on April 23, 2020 at ...
PHILADELPHIA, PA / ACCESSWIRE / April 25, 2020 / Kaskela Law LLC is investigating Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (NASDAQ:MMSI) on behalf of the Company's ...
The WRAPSODY system is a flexible self-expanding endoprosthesis indicated for use in hemodialysis patients for the treatment of stenosis or occlusion within central veins as well as the dialysis outflow circuit of an arteriovenous (AV) fistula or AV graft. Merit has worked for almost eight years to design, develop and establish the appropriate technology and manufacturing capabilities for this product. Merit recently completed enrollment and primary follow-up of its WRAPSODY FIRST study which included 46 patients in Europe.
Nominates Three Medical Device Industry Veterans – Lonny Carpenter, David Floyd and James Hogan – for Election to the Board of Directors Announces Formation of Operating.
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Q1 2020 worldwide revenue of $243.5 million, up 2.2% as reported over Q1 2019Q1 2020 core revenue on a constant currency basis* up 3.0% over Q1 2019Q1 2020 GAAP loss per share.
The kit will be produced at Merit’s facility in South Jordan, Utah, with other Utah companies providing various services. For the last several weeks, officials from Merit and the State of Utah have been working together in anticipation of an impending swab shortage. “We have directed resources to the development of this kit, and our engineers, technicians, marketers and production staff have responded by working tirelessly to bring this important product to market in 30 days,” said Fred P. Lampropoulos, Merit’s Chairman and CEO.
Merit Medical Systems (MMSI) has registered an increase in revenues at both its key operating segments in Q1
SAN DIEGO, CA / ACCESSWIRE / May 19, 2020 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in (NYSE:MMSI) shares. Investors, who purchased shares of Merit Medical ...
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
A Relative Strength Rating upgrade for Merit Medical Systems shows improving technical performance. Will it continue?
SOUTH JORDAN, Utah, April 14, 2020 -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in.
Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics.
Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Merit Medical Systems, Inc. (NASDAQ: MMSI) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between February 26, 2019 and October 30, 2019. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics.